Ian Chapman

Ian Chapman currently serves as Vice President and Senior Director, Head of Nonclinical Consulting at ICON plc, a leading global drug development services company. With a career spanning several decades, Ian has held prominent roles including Senior Director of Preclinical Development at Aptiv Solutions, Development Director at FulcrumPharma, Director of Pharmacology at Quintiles, Head of Respiratory Research at Syntex Pharma, and Group Head of the Preclinical Respiratory Group at Sandoz. Ian holds a PhD in Pharmacology from the University of Bristol, earned from 1983 to 1986, underscoring a solid academic foundation in the field.